Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

FDA Approves BRAVECTO® QUANTUM Injectable from Merck Animal Health

  • The Pharma Data
  • July 11, 2025

FDA Approves Merck Animal Health’s BRAVECTO® QUANTUM, a Year-Long Injectable Flea and Tick Treatment for Dogs Merck Animal Health, a division of Merck & Co., announced FDA approval of BRAVECTO®…

Read MoreFDA Approves BRAVECTO® QUANTUM Injectable from Merck Animal Health
  • Regulatory

FDA Accepts Merck’s NDA for Once-Daily HIV-1 Treatment

  • The Pharma Data
  • July 11, 2025

Merck’s NDA for Once-Daily Doravirine/Islatravir HIV Regimen Accepted by U.S. FDA Merck, known as MSD outside the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) has…

Read MoreFDA Accepts Merck’s NDA for Once-Daily HIV-1 Treatment
  • Press Releases

AbbVie and IGI Announce Exclusive Worldwide Licensing Deal for First-in-Class Trispecific Antibody ISB 2001

  • The Pharma Data
  • July 11, 2025

AbbVie and IGI Therapeutics Sign Exclusive Global Licensing Agreement for Trispecific Antibody ISB 2001 AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of Ichnos Glenmark Innovation, Inc. (IGI), today…

Read MoreAbbVie and IGI Announce Exclusive Worldwide Licensing Deal for First-in-Class Trispecific Antibody ISB 2001
  • News

EU Approves TEVIMBRA+Chemo for First-Line Nasopharyngeal Cancer

  • The Pharma Data
  • July 10, 2025

BeOne, a global oncology company, today announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with gemcitabine and cisplatin for the first-line treatment of adult patients with metastatic…

Read MoreEU Approves TEVIMBRA+Chemo for First-Line Nasopharyngeal Cancer
  • Regulatory

FDA Accepts Taiho’s Supplemental New Drug Application

  • The Pharma Data
  • July 10, 2025

FDA Accepts sNDA for INQOVI® Plus Venetoclax for Newly Diagnosed AML Patients Ineligible for Intensive ChemotherapyCombination therapy met primary efficacy endpoint with no new safety signals; would represent the first…

Read MoreFDA Accepts Taiho’s Supplemental New Drug Application
  • News

Otsuka Launches POCARI SWEAT in India, Boosts Global Nutraceutical Expansion

  • The Pharma Data
  • July 10, 2025

Otsuka Pharmaceutical Launches POCARI SWEAT in India, Strengthening Global Nutraceutical Expansion Otsuka Pharmaceutical Co., Ltd. (Otsuka) has officially launched sales of its popular health drink, POCARI SWEAT, in India as…

Read MoreOtsuka Launches POCARI SWEAT in India, Boosts Global Nutraceutical Expansion
  • News

IZERVAY™ Generates Early Sales Momentum

  • The Pharma Data
  • July 10, 2025

Astellas Reports Preliminary U.S. Sales of IZERVAY™ Reach ¥15.9 Billion ($110 Million) in Q1 FY2025 Astellas Pharma , a leading global pharmaceutical company under the leadership of President and CEO…

Read MoreIZERVAY™ Generates Early Sales Momentum
Biogen
  • News

Six Innovative Startups Redefining Aging

  • The Pharma Data
  • July 10, 2025

The Longevity Revolution: Six Biotech Startups Transforming How We Age Armed with cutting-edge biological science, advanced computational tools, and deep-pocketed investors, a new wave of biotech startups is targeting what…

Read MoreSix Innovative Startups Redefining Aging
  • Regulatory

FDA Moves to Update Label of Lilly’s Alzheimer’s Drug to Curb Safety Issues

  • The Pharma Data
  • July 10, 2025

FDA Approves Label Update for Lilly’s Alzheimer’s Drug Kisunla in Bid to Enhance Safety and Broaden Use The U.S. Food and Drug Administration (FDA) has approved a significant label update…

Read MoreFDA Moves to Update Label of Lilly’s Alzheimer’s Drug to Curb Safety Issues
  • News

Trump Announces Potential 200% Tariffs on Drug Imports, Offers One-Year Transition

  • The Pharma Data
  • July 10, 2025

Trump Floats 200% Tariffs on Pharma Imports, Offers Industry One-Year Grace Period In a move that could significantly reshape the pharmaceutical supply chain and global drug trade, President Donald Trump…

Read MoreTrump Announces Potential 200% Tariffs on Drug Imports, Offers One-Year Transition
  • News

Supreme Court Lifts Ban on RFK Jr.’s Health Department Funding Cuts

  • The Pharma Data
  • July 10, 2025

Supreme Court Halts Injunction, Allowing RFK Jr.’s HHS Workforce Cuts to Move Forward The U.S. Supreme Court on Tuesday issued a stay that permits the Trump administration to proceed with…

Read MoreSupreme Court Lifts Ban on RFK Jr.’s Health Department Funding Cuts
  • Business

Merck Expands Respiratory Portfolio With $10B Verona Acquisition

  • The Pharma Data
  • July 10, 2025

Merck Bolsters Respiratory Portfolio With $10B Verona Acquisition Ahead of Keytruda Patent Cliff In the second-largest biopharma acquisition of 2025, Merck is acquiring Verona Pharma for $10 billion, a strategic…

Read MoreMerck Expands Respiratory Portfolio With $10B Verona Acquisition
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Synthetic Design Lab Debuts First Logic-Gated ADC at AACR 2026, Delivering ≥10X Enhanced Targeted Cancer Cell Killing
  • Lundbeck Showcases Real-World Improvements in Migraine-Related Cognitive Symptoms with VYEPTI® at AAN 2026
  • Zai Lab Highlights Preclinical Data Showing ZL-1503 Delivers Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.